Trials / Sponsors / JI-YOUN HAN
JI-YOUN HAN
Other Government · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays Non Small Cell Lung Cancer | Phase 2 | 2020-05-15 |
| Completed | BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer Small Cell Lung Cancer, Small Cell Lung Cancer Recurrent | Phase 2 | 2011-12-01 |